166 related articles for article (PubMed ID: 11446484)
1. Central nervous system involvement in gestational trophoblastic neoplasia.
Altintaş A; Vardar MA
Eur J Gynaecol Oncol; 2001; 22(2):154-6. PubMed ID: 11446484
[TBL] [Abstract][Full Text] [Related]
2. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
Cagayan MS; Lu-Lasala LR
J Reprod Med; 2006 Oct; 51(10):785-92. PubMed ID: 17086807
[TBL] [Abstract][Full Text] [Related]
3. Management of drug resistant gestational trophoblastic neoplasia.
Patel SM; Desai A
J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
[TBL] [Abstract][Full Text] [Related]
4. Gestational trophoblastic disease metastatic to the central nervous system.
Evans AC; Soper JT; Clarke-Pearson DL; Berchuck A; Rodriguez GC; Hammond CB
Gynecol Oncol; 1995 Nov; 59(2):226-30. PubMed ID: 7590478
[TBL] [Abstract][Full Text] [Related]
5. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
6. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
7. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
8. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
[TBL] [Abstract][Full Text] [Related]
9. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
Kohorn EI
Gynecol Oncol; 1993 Sep; 50(3):300-4. PubMed ID: 8406191
[TBL] [Abstract][Full Text] [Related]
10. Placental site trophoblastic tumor: an overview.
Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; Cantú MG
J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
[TBL] [Abstract][Full Text] [Related]
11. Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.
Cyriac S; Rajendranath R; Sridevi V; Sagar TG
J Reprod Med; 2011; 56(5-6):219-23. PubMed ID: 21682117
[TBL] [Abstract][Full Text] [Related]
12. [Study on the indication of surgical resection of pulmonary metastasis of malignant trophoblastic tumor].
Zhang Y; Xiang Y; Ren T; Wan XR; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):83-6. PubMed ID: 15840284
[TBL] [Abstract][Full Text] [Related]
13. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
Dgani R; Zalel Y; Biran H; Blickstein I; Caspi B; Weissman A; Shoham Z
Eur J Obstet Gynecol Reprod Biol; 1994 Mar; 54(1):77-9. PubMed ID: 7519153
[TBL] [Abstract][Full Text] [Related]
14. Gestational trophoblastic disease: the significance of vaginal metastases.
Vardar MA; Altintaş A; Demir SC
Eur J Gynaecol Oncol; 2000; 21(2):184-6. PubMed ID: 10843482
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
Song SQ; Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
[TBL] [Abstract][Full Text] [Related]
16. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
Lurain JR; Schink JC
J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
[TBL] [Abstract][Full Text] [Related]
17. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
[No Abstract] [Full Text] [Related]
18. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
19. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Surwit EA; Childers JM
J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
[TBL] [Abstract][Full Text] [Related]
20. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
